| Personalized Therapeutics: A Potential Threat to Health Equity. | |
| | |
MedLine Citation:
|
PMID: 22311335 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Throughout history, medical advances have been adopted first and preferentially by the well educated and economically advantaged groups. The development of personalized therapeutics holds promise to fundamentally alter the practice of clinical medicine, but if it also is used preferentially by economically advantaged groups, this advance will likely worsen socioeconomic disparities in health. Prospective development of strategies to ensure non- differential access to these therapies may help limit this unintended consequence of medical progress for economically disadvantaged groups. |
| | |
Authors:
|
Michael M Ward |
Related Documents
:
|
12613295 - How to safely maintain equipment where hazardous materials may lurk. 16209155 - Bacitracin. 22556455 - Medical treatment and medicinal charms mentioned in the atharvanic literature. 8006625 - Asbestos exposure and cancerphobia. 863065 - Topical parabens: benefits and risks. 4043605 - Physician redistribution: a worldwide medical problem. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-2-7 |
Journal Detail:
|
Title: Journal of general internal medicine Volume: - ISSN: 1525-1497 ISO Abbreviation: - Publication Date: 2012 Feb |
Date Detail:
|
Created Date: 2012-2-7 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8605834 Medline TA: J Gen Intern Med Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Intramural Research Program, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA, wardm1@mail.nih.gov. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Electronic Medical Record Availability and Primary Care Depression Treatment.
Next Document: NF-?B as a potential therapeutic target in microbial diseases.